Navigation Links
One Pill may Be Better Than Two for Treating Patients With High Blood Pressure

Adults with high blood pressure and additional risk factors for heart disease may benefit more from taking one tablet rather than two , if their current treatment combines the lipid-lowering medication atorvastatin with the blood pressure-lowering medication amlodipine, researchers reported at the American Heart Association's 8th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke.

In an analysis, researchers found that a single-tablet combination of the two medications is less costly than a two-tablet combination and is at least as effective, if not more so, in preventing cardiovascular events. Patients take the single-tablet medication or the two-tablet medication daily.

'This is a novel research approach that examines the economic and clinical implications of high blood pressure and cholesterol in the real world,' said Timothy W. Smith, lead author of the study and senior director of Informatics for ValueMedics Research (a unit of IMS Health Inc), a health outcomes research and consulting firm in Falls Church, Va. Researchers used a treatment approach and a population similar to the Anglo-Scandinavian Cardiac Outcomes Trial Lipid-Lowering Arm (ASCOT-LLA), which demonstrated the benefits of adding atorvastatin to high blood pressure treatment in adults with three or more risk factors for heart disease, including abnormal ratio of total-to-high density lipoprotein (HDL the 'good' cholesterol), previous stroke, male gender, 55 years or older and smoking.

In ASCOT-LLA, researchers examined 10,305 patients with high blood pressure and additional risk factors for heart disease with lowto-moderate cholesterol levels and found the addition of atorvastatin to high blood pressure treatment resulted in a significant reduction in unfavorable outcomes: fatal and non-fatal heart attack, stroke and chest pain. Nearly one in three U.S. adults has high blood pressure. About one-third of them do not know they have it. Uncontrolled high blood pressure can lead to stroke, heart attack, heart failure or kidney failure.

High blood pressure is defined as systolic pressure of 140 mm Hg or higher or diastolic pressure of 90 mm Hg or higher. Systolic pressure is the force of blood in the arteries when the heart contracts to pump blood to the body. Diastolic pressure is the force in the arteries when the heart relaxes between beats. Normal blood pressure is less than 120 mm Hg systolic pressure and less than 80 mm Hg diastolic pressure.

The results of the study showed that when hypothetical cohorts of 100,000 people fully adhered to the one-tablet and two-tablet regimens, each treatment group had 3,520 cardiovascular events over four years, such as fatal and non-fatal heart attack, chest pain and stroke. Medical costs over four years were $7,665 for the two-tablet regimen and $6,471 for the one-tablet regimen.

A further analysis, examining the impact of lower compliance more typical in real-world populations, showed that four-year cardiovascular events increased for the two-tablet regimen to 6,990 versus 6,859 for the one-tablet regimen. Researchers concluded the one-tablet regimen was less costly and at least as effective as the two-tablet regimen. Sensitivity analyses confirmed these results when varying the effectiveness associated with partial adherence from 0 percent to 100 percent of the effectiveness of full adherence.

Researchers in the ValueMedics study used U.S. databases to estimate direct medical costs and adverse treatment outcomes over four years among adults with similar characteristics to those examined in ASCOT-LLA. Amlodipine (brand name Norvasc) is in a class of medications called calcium channel blockers. It lowers blood pressure by relaxing the blood vessels so the heart does not have to pump as hard.

Atorvastatin (brand name Lipitor) is in a class of medications known as sta tins or HMG-CoA reductase inhibitors. It lowers the level of cholesterol in the blood.

A single tablet combination of amlodipine/atorvastatin is available as Caduet.


'"/>




Related medicine news :

1. Better prostate cancer detection
2. Better Treatment for obesity
3. For a Better Memory
4. Baby Talk Better Than Adult Speech
5. Drug Combo Works Better for children with ADHD, Tics
6. Better skin with lasers
7. Better diabetes treatment promises Vanadium
8. Better Prostate Cancer Test
9. Better Drug for Heart Transplant
10. Better Diet Even Late in Life May Prolong It
11. Better Care Required for Breast Cancer Survivors
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/23/2017)... ... January 23, 2017 , ... The Masters of Science in ... leaders with decades of experience who remain current practitioners in the field. With ... there is a renewed demand for versatile, data-driven leadership.The American University’s MS in ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... Living (IHCA/INCAL), will serve as a healthcare industry expert at the 2017 Sector ... discussion, moderated by Inside Indiana Business host Gerry Dick, will feature an employer ...
(Date:1/23/2017)... Oregon (PRWEB) , ... January 23, 2017 , ... ... announced today it has earned organic certification under the USDA National Organic Program ... USDA Organic Certification process, we have established organic production and handling systems to ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... in partnership with the American Society of Anesthesiologists® (ASA®), the Foundation for ... American Academy of Orthopaedic Surgeons (AAOS) and the Cigna Foundation, encourages proposals ...
(Date:1/23/2017)... ... 2017 , ... “Crossing the Bar”: a moving and eloquent drama depicting ... the Bar” is the creation of published author, Charlotte Hotte, a North Carolina native, ... the inspiration of the book to her sister, Denise, wishes to acknowledge her savior, ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... Calif. , Jan. 23, 2017  Based ... market, Frost & Sullivan recognizes Ansell, a global ... Frost & Sullivan Company of the Year Award. ... approach, and a wide global footprint have placed ... the hand protection market. The Company,s established product ...
(Date:1/23/2017)... , Jan. 23, 2017 MouthWatch LLC announced ... was ranked as the best intraoral camera on DentalCompare,s ... the #2 spot overall. The #1 product was the ... the MouthWatch intraoral camera was "…incredibly popular because it is ... camera has a small sticker price, it doesn,t sacrifice quality ...
(Date:1/23/2017)... 2017 Direct-to-consumer digital ... sold and 65% increase in consumable sales, quarter-over-quarter ... (NASDAQ: DRIO ), a leader in digital ... the Dario™ Blood Glucose Monitoring System, an all-in-one diabetes ... app-based and minimally invasive smart diabetes management solution. ...
Breaking Medicine Technology: